|Bid||11.90 x 800|
|Ask||12.13 x 900|
|Day's Range||12.05 - 12.46|
|52 Week Range||10.66 - 22.89|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||79.93|
|Earnings Date||Oct 25, 2021 - Oct 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 31, 2018|
|1y Target Est||23.40|
Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2021 third quarter earnings investor webcast on Tuesday, November 2, 2021 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
The mean of analysts' price targets for Zynex Inc. (ZYXI) points to an 86.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q3 2021.